Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phenothiazine chloride is a small molecule photosensitizer belonging to the phenothiazine dye class, primarily utilized in antimicrobial photodynamic therapy (aPDT). In clinical research, specifically studies led by the University of Zurich, it is applied topically into periodontal pockets to treat chronic periodontitis. The mechanism involves the formation of metachromatic complexes with bacterial lipopolysaccharides; upon activation by light at wavelengths of approximately 635–670 nm (typically via laser or LED), the compound generates cytotoxic reactive oxygen species that target and destroy bacterial cell structures. It is currently used as an investigational agent in dental research rather than a commercially approved pharmaceutical product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phenothiazine chloride.